Navigation Links
AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
Date:10/29/2010

ALISO VIEJO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) capsules, as the first treatment for pseudobulbar affect.  

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA).  PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying.  PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state.    

"The FDA approval of NUEDEXTA marks an important milestone for people living with PBA, an under-recognized and debilitating neurologic condition," said Keith Katkin, president and chief executive officer of Avanir.  "The approval of NUEDEXTA also marks AVANIR's transition toward becoming a commercial enterprise, ready to support the successful launch of the first FDA-approved treatment for PBA. We expect that NUEDEXTA will be available by prescription during the first quarter of 2011."

"This FDA approval represents a significant step forward for people who live with the debilitating effects of PBA," said Dr. Nicholas LaRocca, Vice President of Healthcare Delivery and Policy Research at the National MS Society. "For people who experience unexplained bouts of inappropriate laughing or crying, this new therapy has the potential to substantially help both them and their families."

"Today's approval of NUEDEXTA is a testament to the conviction of the patients and researchers who participated in our studies and represents over 10 years of research and development by our dedicated employees," said Randall Kaye, MD, Chief Medical Officer, AVANIR Pharmaceuticals. "We are very plea
'/>"/>

SOURCE AVANIR Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) announced ... elected to its Board of Directors.  She most recently ... well as President of Covidien,s Vascular Therapies Division from ... to 2012. Ms. Enxing Seng joined Covidien ... where she was a founding member and executive officer ...
(Date:3/4/2015)... Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the ... China, today announced its financial results for the fourth ... Quarter 2014 Financial Highlights , Total sales ... or 36.8% excluding the impact of foreign currency exchange ... the same quarter of 2013. , Gross profit ...
(Date:3/4/2015)... , March 4, 2015 Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... will ring The Opening Bell ® of the ... 2015. Asterias began trading as an NYSE MKT listed ... York Stock Exchange is a trusted partner to Asterias ...
Breaking Medicine Technology:Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3
(Date:3/5/2015)... 2015 Wimbledon Health Partners , ... echocardiogram and NCV testing, announced the addition ... Medical Officer. Dr. Artel will be responsible for medical ... WimbledonMED program and the continued growth and support of ... with Wimbledon Health Partners as a consulting physician since ...
(Date:3/5/2015)... March 5, 2015 – As National Patient Safety ... 2015), children’s hospitals around the country are affirming the ... as safe as possible for their children. , A ... Patient Safety (SPS) and the Children’s Hospital Association—are collaborating ... visiting the hospital with their child. , “SPS ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been developed ... of dental disciplines, to offer implant placement treatment to ... we wanted this course to be a truly empowering ... of the lecturers and the sheer energy and enthusiasm ... our aims." , Unlike large-scale training operations, the ...
(Date:3/5/2015)... What makes a legend? In the case of renowned ... of exceptional courtroom performance, championing big causes and underdogs alike ... brilliant service, the Dallas Bar Association has named Schmidt a ... at a luncheon on Tuesday, April 7, 2015 at 12 ... nominees for this year are Bob Vial, Deborah Hankinson and ...
(Date:3/5/2015)... March 05, 2015 Lakeview Regional ... support of the annual American Heart Association’s Heart Walk ... Kolman, Lakeview Regional Chief Executive Officer, is serving as ... Saturday, March 21, 2015 at Fontainebleau State Park beginning ... Regional has 20 individual teams participating in this year’s ...
Breaking Medicine News(10 mins):Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3
... , , FRAMINGHAM, Mass., ... HTWR ) (ASX: HIN) announced today the completion of its offering ... private placement in the United States and Australia (the "Offerings"). ... of US$22.00 per share resulting in gross proceeds of approximately US$60 ...
... records points to an epidemic at the time, , MONDAY, ... of classical music: What -- or who -- killed Mozart at ... his creative powers? , Now, there,s a new theory: He died ... inherent drama of murder by a rival or suicide, which have ...
... Aug. 17 Insulet Corporation (Nasdaq: PODD ), the ... Management System, today announced the appointment of Peter J. Devlin ... Devlin will lead the Company,s Sales and Marketing, Business Development, ... "Peter brings a distinguished track record in the diabetes ...
... mortality risk, study suggests , MONDAY, Aug. 17 (HealthDay ... the risk of death among people with peripheral arterial ... when plaque accumulates in arteries that supply blood to ... brain. , The study included 184 PAD patients, average ...
... common vitamin and mineral supplements, , MONDAY, Aug. 17 (HealthDay ... increase the risk for melanoma, the most serious form of ... had suggested that the risk for melanoma was increased four-fold ... carotene, selenium and zinc. Because 48 to 55 percent of ...
... , , ALBANY, N.Y., ... (NYSDOT) announced that tomorrow, August 18, 2009, will be an ... be unhealthy, especially for sensitive individuals, such as children, seniors ... forecasted high levels of both particulate matter and ground-level ozone ...
Cached Medicine News:Health News:HeartWare International, Inc. Closes US$60 Million Financing 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 3Health News:Strep Throat May Have Led to Mozart's Death 2Health News:Strep Throat May Have Led to Mozart's Death 3Health News:Insulet Appoints Peter J. Devlin as Chief Commercial Officer 2Health News:Worries May Worsen Peripheral Arterial Disease 2Health News:Antioxidants Pose No Melanoma Threat 2Health News:Antioxidants Pose No Melanoma Threat 3Health News:Air Quality Action Day Declared for Tuesday, August 18, 2009 2
Detect LH surge for predicting ovulation, Able to detect as low as 40 mIU/mL LH or 30 mIU/mL LH, Simple, easy and accurate, Built-in control system...
... Fertility Monitor has been designed for women actively ... algorithm to help identify the time of high ... before a woman reaches her peak fertility. By ... The product comprises a number of test sticks ...
... enables the fast and exact determination of ... handy photometer and micro-cuvettes, filled with dry ... or arterial blood should be taken with ... so filled cuvette can now be inserted ...
STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Medicine Products: